These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28378237)

  • 21. The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models.
    Andrašina T; Jaroš J; Jůza T; Rohan T; Červinka D; Crha M; Válek V; Goldberg NS
    Cardiovasc Intervent Radiol; 2019 May; 42(5):751-762. PubMed ID: 30761413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The injury of recurrent laryngeal nerve and thyroid regeneration after irreversible electroporation ablation of most part of thyroid gland-an experimental study on swine model.
    Li S; Yun M; Tian L; Wu P; Liu L
    Endocr J; 2019 Nov; 66(11):1017-1027. PubMed ID: 31391353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liver regeneration after radiofrequency ablation versus irreversible electroporation].
    Li S; Zeng Q; Zhong R; Mao S; Shen L; Wu P
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(1):66-8. PubMed ID: 25876814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effects of Irreversible Electroporation on the Colon in a Porcine Model.
    Luo X; Liang X; Li J; Shi J; Zhang W; Chai W; Wu J; Guo S; Fang G; Zhou X; Zhang J; Xu K; Zeng J; Niu L
    PLoS One; 2016; 11(12):e0167275. PubMed ID: 27907057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible Electroporation of the Pancreas Using Parallel Plate Electrodes in a Porcine Model: A Feasibility Study.
    Rombouts SJ; Nijkamp MW; van Dijck WP; Brosens LA; Konings M; van Hillegersberg R; Borel Rinkes IH; Hagendoorn J; Wittkampf FH; Molenaar IQ
    PLoS One; 2017; 12(1):e0169396. PubMed ID: 28052102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irreversible electroporation in eradication of rabbit VX2 liver tumor.
    Lee EW; Wong D; Tafti BA; Prieto V; Totonchy M; Hilton J; Dry S; Cho S; Loh CT; Kee ST
    J Vasc Interv Radiol; 2012 Jun; 23(6):833-40. PubMed ID: 22534357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Effectiveness of Irreversible Electroporation in Lymph Node Metastases.
    Narayanan G; Mahendra AM; Gentile NT; Schiro BJ; Gandhi RT; Peña CS; Dijkstra M
    Cardiovasc Intervent Radiol; 2024 Aug; 47(8):1066-1073. PubMed ID: 38943032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of simulation-based treatment planning with imaging and pathology outcomes for percutaneous CT-guided irreversible electroporation of the porcine pancreas: a pilot study.
    Wimmer T; Srimathveeravalli G; Gutta N; Ezell PC; Monette S; Kingham TP; Maybody M; Durack JC; Fong Y; Solomon SB
    J Vasc Interv Radiol; 2013 Nov; 24(11):1709-18. PubMed ID: 23891044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible electroporation of the pig kidney with involvement of the renal pelvis: technical aspects, clinical outcome, and three-dimensional CT rendering for assessment of the treatment zone.
    Sommer CM; Fritz S; Wachter MF; Vollherbst D; Stampfl U; Bellemann N; Gockner T; Mokry T; Gnutzmann D; Schmitz A; Knapp J; Longerich T; Kuhn-Neureuther C; Pereira PL; Kauczor HU; Werner J; Radeleff BA
    J Vasc Interv Radiol; 2013 Dec; 24(12):1888-97. PubMed ID: 24267525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible electroporation ablation of the liver can be detected with ultrasound B-mode and elastography.
    Au JT; Kingham TP; Jun K; Haddad D; Gholami S; Mojica K; Monette S; Ezell P; Fong Y
    Surgery; 2013 Jun; 153(6):787-93. PubMed ID: 23489942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations.
    Li J; Zhang XB; Wang JJ; Jin LJ; Shan HS; Zhang X; Ma L; Xue XD; Zhang X; Zhang ZL; Meng LL; Yuan F; Xiao YY
    Chin Med J (Engl); 2021 Jun; 134(17):2081-2090. PubMed ID: 34172620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible electroporation ablation: is all the damage nonthermal?
    Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
    Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Irreversible Electroporation on the Femur: Experimental Study in a Rabbit Model.
    Song Y; Zheng J; Yan M; Ding W; Xu K; Fan Q; Li Z
    Sci Rep; 2015 Dec; 5():18187. PubMed ID: 26655843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.
    Lee EW; Chen C; Prieto VE; Dry SM; Loh CT; Kee ST
    Radiology; 2010 May; 255(2):426-33. PubMed ID: 20413755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of magnetic anchoring electrode-assisted irreversible electroporation for gastric tissue ablation.
    Ren F; Li Q; Hu L; Yan X; Gao Z; Zhang J; Gao W; Zhang Z; Chang P; Chen X; Chu D; Wu R; Lv Y
    Surg Endosc; 2020 Feb; 34(2):580-589. PubMed ID: 31011863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.
    Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM
    Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.
    Scheffer HJ; Nielsen K; de Jong MC; van Tilborg AA; Vieveen JM; Bouwman AR; Meijer S; van Kuijk C; van den Tol PM; Meijerink MR
    J Vasc Interv Radiol; 2014 Jul; 25(7):997-1011; quiz 1011. PubMed ID: 24656178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac impact of high-frequency irreversible electroporation using an asymmetrical waveform on liver in vivo.
    Li J; Wang J; Zhang X; Zhang X; Gao H; Xiao Y
    BMC Cardiovasc Disord; 2021 Dec; 21(1):581. PubMed ID: 34876030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.